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Ferritin gene expression is complex and is controlled at transcriptional level in response to a variety of stimuli such as hormones, cytokines and
cAMP. Iron, hemin and several compounds, chemically different, also activate the transcription of the ferritin gene. Ferritin biosynthesis is mainly
regulated at post-transcriptional level by iron regulatory proteins (IRP1 and IRP2). We previously reported that oxalomalate, a competitive
inhibitor of aconitase, remarkably decreases the IRP1 RNA-binding activity and induces a significant increase of ferritin expression. Here, we
examined in cells cultured in presence of OMA the IRP1 intracellular content, ferritin biosynthesis and the transcriptional efficiency of H-ferritin
gene promoter. Our results demonstrate a peculiar role of OMA that rapidly inactivates IRP1 without affecting IRP1 protein content and
subsequently activates H-ferritin gene transcription leading to an overall increase of ferritin biosynthesis. We conclude that OMA regulates H-
ferritin biosynthesis acting early at the post-transcriptional level and later on at transcriptional level.
© 2006 Elsevier B.V. All rights reserved.Keywords: Oxalomalate; Iron metabolism; Ferritin; Iron Regulatory Protein; Transcription; H-ferritin promoter1. Introduction
Oxalomalate, a tricarboxylic acid (OMA, α-hydroxy-β-
oxalosuccinic acid), has long been known to be a potent
competitive inhibitor of aconitase and NADP+-specific iso-
citrate dehydrogenase [1,2]. It can be formed in vitro and in vivo
by condensation of oxaloacetate with glyoxylate. In fact, it is
produced in vitro by a non-enzymatic aldol condensation
between oxaloacetate with the highly reactive glyoxylate [3,4].
This reaction occurs also in vivo by injecting animals with
equimolar quantity of both compounds [5] or could occur in
mammalian cells under physiological conditions when oxalo-
acetate and glyoxylate are present, the latter being synthesized
and catabolized also in cells of vertebrate [6–8].⁎ Corresponding author. Tel.: +39 081 678421; fax: +39 081678403.
E-mail address: rsantama@unina.it (R. Santamaria).
1 These authors contributed equally to this work.
0167-4889/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2006.03.010Ferritin, a ubiquitous protein required for intracellular iron
storage with an approximate molecular mass of 450 kDa,
contains 24 subunits of heavy (H) and light (L) types. H-subunit
has ferroxidase activity that results in the conversion of soluble
Fe(II) into inert aggregate of Fe(III) hydroxides [9]. L-subunit
lacks of the ferroxidase activity and provides efficient sites for
iron nucleation [10]. Ferritin, with its ability to sequester iron
and prevent the formation of reactive oxygen species, has been
linked to enhanced cellular protection against iron-induced
cytotoxicity [11].
Ferritin gene expression is complex and is controlled at trans-
criptional and post-transcriptional levels. The translation of H-
and L-ferritinmRNA is stimulated by iron. In fact, changes in iron
availability regulate ferritin expression through specific protein-
RNA interactions between iron regulatory proteins (IRP1 and
IRP2) and iron responsive elements (IREs) contained within the
5′ UTR of the H- and L-ferritin mRNA [12]. When intracellular
concentrations of iron are low, IRPs binding to IRE cis-elements
represses ferritin translation; reversely, when intracellular
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ferritin mRNA is efficiently translated [13]. IRP1 is a bifunctional
protein that, through [4Fe–4S] cluster assembly/disassembly,
switches from the aconitase formwith enzymatic activity, to IRP1
form with IRE-binding activity, in response to cellular iron level
[9]. IRP1 activity is also subjected to regulation by other factors,
such as nitric oxide signalling [14], oxidative stress [15], phos-
phorylation [16] and hypoxia [17–19].
The transcription of the H- and L-ferritin genes is stimulated
during cell differentiation and neoplastic transformation as well as
in response to a variety of stimuli [9]. The H gene promoter is up-
modulated by different hormones, cytokines and by cAMP [11].
Iron and hemin also activate transcription of H-ferritin genes in
different cell lines [20–22]. Moreover, several agents, such as
hydrogen peroxide [23], tert-butylhydroquinone (tBHQ) [24],
sodium arsenite [25], phorone [26] or diallyl disulfide [27] have
been shown to up-regulate the transcription of ferritin. All these
compounds are chemically different, and the ferritin activation by
these agents is thought to be a stress response mechanism that
contribute to limiting cellular damage from these xenobiotics [11].
We previously reported that OMA remarkably decreases the
IRP1 RNA-binding activity in both iron-repleted and in iron-
depleted cells [5]. Recently, we demonstrated that OMA
induces a significant increase of ferritin protein and mRNA
content in various cell lines [28]. This increased ferritin
expression could result from an OMA-induced post-transcrip-
tional regulation coupled with a modulation of ferritin gene
transcription. This observation prompted us to further investi-
gate the effect of OMA on ferritin expression regulation. Thus,
we examined the IRP1 intracellular content, ferritin biosynthe-
sis and the transcriptional efficiency of H-ferritin gene promoter
in cells cultured in presence of OMA. The results demonstrate a
peculiar role of OMA that rapidly inactivates IRP1 without
affecting IRP1 protein content and later activates H-ferritin gene
transcription leading to an overall increase of ferritin biosyn-
thesis. Our results highlight the bifunctional role of OMA as
regulator of IRP1 activity and ferritin transcription, acting early
on ferritin synthesis IRP-mediated and later on ferritin synthesis
transcriptionally-mediated.
2. Material and methods
2.1. Cell cultures and treatments
3T3-L1 mouse embryo fibroblasts obtained from the European Collection of
Cell Cultures (ECACC), were grown in Dulbecco's modified Eagle's medium
(DMEM) containing high glucose (4.5 g/l), and supplemented with 10% fetal
bovine serum, L-glutamine (2 mM), penicillin (100 units/ml) and streptomycin
(100 μg/ml). Cells were cultured at 37 °C in a humidified 5% CO2 atmosphere.
Confluent cultures were incubated for different times at 37 °C with 5 mM OMA
added to themedium containing 5% fetal bovine serum.Oxalomalic acid trisodium
salt was purchased from Sigma Aldrich (St. Louis, MO, USA).
2.2. Preparation of cytosolic extracts
Cells were washed and scraped off with phosphate-buffered saline (PBS)
containing 1 mM EDTA. To obtain cytoplasmic extracts, cells were lysed with
buffer containing 10mMHEPES, pH 7.5, 3mMMgCl2, 40mMKCl, 5%glycerol,
1mMdithiothreitol (DTT) and 0.2%Nonidet P-40 (NP-40) at 4 °C. Cell debris andnuclei were removed by centrifugation at 15,000×g for 10 min at 4 °C and
supernatants were stored at −80 °C. The protein concentration was determined by
the Bio-Rad protein assay, based on Bradford method, according to the supplier's
manual (Bio-Rad Laboratories, Milan, Italy).
2.3. Electrophoretic mobility-shift assay (EMSA)
Plasmid pSPT-fer, containing the sequence corresponding to the IRE of the H-
chain of human ferritin, linearized at the BamHI site, was transcribed in vitro as
previously described [29]. For RNA-protein band-shift analysis, cytosolic extracts
(5 μg) were incubated for 30 min at room temperature with 0.2 ng of in vitro
transcribed 32P-labeled IRE RNA. The reaction was performed in buffer containing
10 mMHEPES, pH 7.5, 3 mMMgCl2, 40 mMKCl, 5% (v/v) glycerol, 1 mMDTT
and 0.07% (v/v) NP-40, in a final volume of 20 μl. To recover total IRP1 binding
activity, cytosolic extracts were pre-incubated for 10 min with 2-mercaptoethanol at
2% (v/v) final concentration, before the addition of 32P-labeled IRERNA.Unbound
RNA was digested for 10 min with 1 unit of RNase T1 (Roche, Mannheim,
Germany) and non specific RNA–protein interactions were displaced by the
addition of 5mg/ml heparin for 10min. RNA–protein complexeswere separated on
6%non denaturing polyacrylamide gel for 2 h at 200V.After electrophoresis, the gel
was dried and autoradiographed at −80 °C. The IRP–IRE complexes were
quantified with a GS-700 imaging densitometer and/or with a GS-505 molecular
imager system (Bio-Rad). The results are expressed as the percentage of IRP
binding activity versus 2-mercaptoethanol-treated sample.
2.4. Western blot analysis
Samples containing 100 μg of proteins were denatured, separated on a 8% SDS-
polyacrylamide gel and electro-transferred onto a nitrocellulose membrane
(Amersham Biosciences, Little Chalfont, Buckinghamshire, UK) using a Bio-Rad
Transblot. Proteinswere visualized on the filters by reversible stainingwith Ponceau-
S solution and destained in PBS.Membraneswere blocked at 4 °C inmilk buffer (1X
PBS, 10% (w/v) non fat dry milk, 0.1% (v/v) Triton X-100) and then incubated for
3 h at room temperature with 1:250 goat polyclonal antibody to human IRP1 (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA). Subsequently, the membranes were
incubated for 90 min at room temperature with donkey peroxidase-conjugated anti-
goat IgG (Biodesign International, Saco, ME, USA). The resulting complexes were
visualized using chemiluminescence Western blotting detection reagents (ECL,
Amersham Biosciences). The optical density of the bands was determined by a GS-
700 imaging densitometer (Bio-Rad). Normalization of results was ensured by
incubating the nitrocellulose membrane in parallel with the actin antibody.
2.5. Metabolic labeling with 35S-methionine/cysteine and
immunoprecipitation
Cells were pre-incubated for 30 min at 37 °C in a methionine-cysteine-free
medium. The medium was removed and the cells were labeled with 80 μCi/ml
Promix L-[35S]-label (Amersham Biosciences) in methionine-cysteine-free
medium for 3 h in absence or presence of 5 mM OMA for different times.
Cells were washed three times with PBS and lysed in buffer containing 50 mM
Tris–HCl, pH 7.5, 150 mM NaCl, 1% (v/v) Triton X-100 and protease inhibitor
tablet (Roche). Aliquots of cytosolic lysates containing 850 μg of proteins were
cleared with protein G PLUS-Agarose (Santa Cruz Biotechnology Inc.). Then,
5 μg of sheep antibody to ferritin from human heart (Biodesign International),
previously conjugated with 30 μl of protein G PLUS-Agarose, were added to the
lysates and incubated overnight at 4 °C. The protein-agarose beads were
pelleted, washed three times with cold lysis buffer and boiled with SDS loading
buffer. Immunoprecipitated proteins were resolved by using 12% SDS-PAGE.
After electrophoresis the gel was treated with Amplify (Amersham Biosciences)
for 30 min, fixed, dried and then visualized by autoradiography. Normalization
of the incorporation of 35S-methionine/cysteine into total proteins was made by
measuring trichloroacetic precipitable radioactive counts or protein content.
2.6. RNA extraction and Northern blot analysis
Total cellular RNAwas isolated from cells by the TRIzol reagent (Invitrogen
Life Technologies, Carlsbad, CA) as indicated in the manufacturer's instructions.
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denaturing formaldehyde gel and then transferred to Hybond-N filters (Amersham
Biosciences). The hybridization was performed for 18 h at 65 °C in 0.5 M sodium
phosphate buffer, pH 7.2, 1 mM EDTA, pH 8.0, 7% (w/v) SDS. The filters were
washed in 0.05 M sodium phosphate buffer pH 7.2, 1% (w/v) SDS at 65 °C and
autoradiographed at−80 °C. A cDNA fragment corresponding to human cDNA for
H-ferritin was 32P-radiolabeled using the random priming method (Amersham
Biosciences). For actinomycin D experiments, cells were incubated with (5 μg/ml)
actinomycin D (Sigma Aldrich) for 24 h in presence or in absence of 5 mMOMA.
The β-actin probe was used to standardize the amounts of mRNA in each lane.
2.7. Reporter vectors and transfection experiments
The H-ferritin promoter/CAT construct 5′-H H/A has been previously
described and contains 100 bp upstream of the transcription start site of the
human H ferritin [30]. The Bbf/TATAA construct contains a double-stranded B-
site oligonucleotide (5′-CGGCGCTGATTGGCCGGGGCGGGC-3′), in the
correct 5′ to 3′ orientation, cloned in the SmaI site of the 5′-H H/M construct
upstream the ferritin TATAA box in the pEMBL8-CAT vector [31]. The Bbfmut/
TATAA construct was obtained by inserting a mutated B-site oligonucleotide (5′-
CGGCTCTTACAGGCCGTTGCGAGC-3′), in the correct 5′ to 3′ orientation, in
the SmaI site of the 5-H H/M construct not recognized by B-site binding factor
[31]. Mouse and human H-ferritin promoter sequences show a high degree of
homology (78%) in the B site [32]. Cells (3×105) were transfected in triplicate
with Lipofectamine™ Reagent (Invitrogen Life Technologies). Each transfection,
according to the manufacturer's instructions, was performed with 10 μl of
Lipofectamine™Reagent and 2 μg of respective plasmid plus 0.2 μg of CMV-Luc
vector, a plasmid carrying the luciferase gene under the control of the
cytomegalovirus enhancer, to correct for variations in DNA uptake and
transfection efficiency. To determine the dose- and time-dependence of OMA
effect, after 24 h of transfection, the cells were treated with various concentrations
of OMA (1, 2.5, 5, 10 mM) or with OMA (5 mM) for 6, 24 and 48 h. Luciferase
activity was then measured in a microplate luminometer (EG and G Berthold, Bad
Wildbad, Germany) as previously described [31]. CAT gene expression was
assessed by measuring the CAT protein levels as relative activity by ELISA
(Roche).
2.8. Nuclear extracts and DNA band-shift
For nuclear extracts preparation, 3T3-L1 cells were treated with 5 mM OMA
for 6, 24 and 48 h, washed twice and harvested with phosphate-buffered saline andFig. 1. (A) Representative electrophoretic mobility-shift assay showing the effect o
fibroblasts. β-mercaptoethanol (2-ME) was added at 2% final concentration to bindi
were quantified by densitometric and/or phosphorimager analysis. The faster migrat
included in the densitometry quantification. The results were plotted in a bar graph as p
are the average±S.E.M. of four independent experiments. (B) Western blot analysis sh
Equal amounts of proteins (100 μg) were separated on 8% SDS-polyacrylamide gel a
actin was used as internal control to standardize the amount of proteins in each lan
analysis. Shown are the mean±S.E.M. of three independent experiments plotted inthen collected by centrifugation. The pellets were resuspended in 50 μl of
hypotonic buffer containing 10 mMHEPES, pH 7.9, 10mMKCl, 1.5mMMgCl2,
0.1mMEGTA, 0.5mMDTT, 0.5mMphenylmethylsulfonyl fluoride (PMSF) and
cell lysis was performed by passing the cells through a syringe's needle. After
centrifugation at 4 °C at 1600×g for 10 min, nuclear fraction was resuspended in
75 μl of saline buffer (10 mM HEPES, pH 7.9, 0.4 M NaCl, 1.5 mM MgCl2,
0.1 mM EGTA, 0.5 mM DTT, 0.5 mM PMSF, 5% glycerol) and passed through a
syringe's needle. Themixturewas incubated for 30min on ice and then centrifuged
at 14,000×g for 30 min. Proteins contained within supernatants were quantified by
the Bio-Rad protein assay. The conditions for the protein–DNA binding reaction
and competition assays were as described previously [33]. The nucleotide
sequences of the probe and of the competitor DNA are: B-oligo 5′-
CGGCGCTGATTGGCCGGGGCGGGC-3′; CTF/NFY 5′-TTATTTTGGATT-
GAAGCCAATATGATAA-3′.
The probes were terminally labeled by using T4 polynucleotide kinase in the
presence of [γ-32P] dATP. Briefly, 5 μg of nuclear extracts were pre-incubated for
15 min in 10 μl of binding buffer (100 μg/ml BSA, 20 mMHEPES, pH 7.9, 50 mM
KCl, 1 mM EDTA, 10% glycerol, 0.5 mMDTT, 40 mMMgCl2, 80 mM spermidin,
2.5μg/ml ssDNA, 1μg/ml poly dI-dC). Then,DNA radiolabeled probe (50,000 cpm)
was added and the mixture was incubated for 15 min at room temperature. Specific
competitions were performed by adding a 100-fold molar excess of the unlabeled B-
site oligonucleotide; non-specific competitions were performed by adding a 100-fold
molar excess of unspecific oligonucleotide. The samples were electrophoresed on a
5% non-denaturing polyacrylamide gel for 2 h at 200 Vat 4 °C. The gels were dried
and subjected to autoradiography at −80 °C. The DNA–protein complexes were
quantified with a GS-700 imaging densitometer (Bio-Rad).
3. Results
3.1. OMA does not affect IRP1 expression
We have recently demonstrated that treatment of several cell
lines with OMA decreases IRP1 RNA-binding activity and
increases ferritin level [28]. To evaluate if the decrease of IRP1
binding activity was due to a variation OMA-induced of IRP1
protein content, we analyzed the IRP1 level in murine fibroblasts,
line 3T3-L1, exposed to 5 mM OMA from 6 to 48 h. The IRP1
protein content and RNA-binding activity were evaluated by
Western blot using anti-IRP1 antibody and by EMSA,f 5 mM OMA for the indicated times on IRP1 IRE-binding in 3T3-L1 murine
ng reaction to determine the total amount of IRP1 activity. IRE/IRP1 complexes
ing band at 6 h and 24 h corresponded to the IRP2–IRE complex and was not
ercentage of the control treated with 2-ME (100% of IRP1 activity, grey bar) and
owing the effect of OMA on IRP1 protein content in 3T3-L1 murine fibroblasts.
nd subjected to Western blot analysis using a goat anti-human IRP1 antibody. β-
e. The bands corresponding to IRP1 protein were quantified by densitometric
bar graph as relative O.D. units.
Fig. 2. Representative ferritin biosynthesis in 3T3-L1 cells cultured in presence
of OMA. During the last 3 h of the OMA incubation, cells were labeled with 35S-
Met/Cys in methionine/cysteine-free medium. Cell extracts were immunopre-
cipitated with sheep anti-human heart ferritin antibody and proteins were then
subjected to 12% SDS-PAGE analysis and autoradiography. The lighter and
faster migrating band may be a contaminant, since the mouse H-subunit has a
higher electrophoretic mobility compared with the L-subunit. The intensity of
the bands corresponding to ferritin was measured by densitometry and is plotted
in bar graph as the mean of relative O.D. units±S.E.M. of three independent
experiments.
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IRP1 was reduced at 6 h of OMA treatment, after which the
activity slightly increased until 48 h remaining at lower level than
untreated cells. A faster migrating band was revealed at 6 h and
24 h, which corresponded to the IRP2–IRE complex. Further-
more, immunoblot analysis did not show any appreciable
variation in the amount of IRP1 protein in all samples (Fig.
1B), suggesting that OMA did not affect the expression of IRP1
protein.Fig. 3. (A) Northern blot analysis showing the effect of 5 mM OMA on H-ferritin mR
were hybridized to H-ferritin cDNA 32P-radiolabeled probe. The β-actin probe was u
H-ferritin mRNAwere quantified by densitometric and/or phosphorimager analysis
independent experiments. (B) Representative Northern blot analysis showing the eff
absence of 5 μg/ml actinomycin D (Act D). Total cellular RNAwas processed as de
evaluated by densitometric and/or phosphorimager analysis. Results are plotted in
experiments.3.2. Ferritin biosynthesis OMA-induced exhibits a biphasic
response
Next, we evaluated ferritin biosynthesis by immunoprecipita-
tion of 35S-labeling in 3T3-L1 cells exposed to OMA from 6 to
48 h and radiolabeled for 3 hwith 35S-Met/Cys.As shown in Fig. 2
the rate of 35S-methionine/cysteine incorporation into ferritin
rapidly enhanced of about 2.2-fold by 6 h of OMA exposure,
progressively declined until 24 h and increased again of about 3.3-
fold at 48 h. These findings are consistent with a biphasic response
of ferritin synthesis induced byOMA exposure. The early increase
in ferritin synthesis at 6 h correlateswith the concomitant reduction
in IRP1 RNA-binding activity, and the decrease at 24 h correlates
with the induction in IRP1 RNA-binding activity (see Fig. 1A).
The maximum increase of ferritin synthesis observed at 48 h
does not strictly correlate with the observed RNA-binding activity
of IRP1 at the same time, consequently other types of regulation
could be implicated.
3.3. Induction of H-ferritin mRNA by OMA requires RNA
synthesis
As shown in Fig. 3A, and partially reported in an other context
[28], exposure of 3T3-L1murine fibroblasts toOMA for 6, 12 and
24 h progressively raised the H-ferritin mRNA content. This
increase of the transcript could result by variation in transcriptional
efficiency of the gene or by increase in the mRNA half-life. To
discriminate which is the involved mechanism, 3T3-L1 cells were
co-treated for 24 hwith 5mMOMAand 5μg/ml actinomycinD, a
transcriptional inhibitor. As shown in Fig. 3B, actinomycin D
completely blocked the OMA-induced increase in H-ferritinNA levels for the indicated times. Equal amounts (10 μg) of total cellular RNA
sed to standardize the amounts of RNA in each lane. The bands corresponding to
and are plotted in bar graph as the mean of relative O.D. units±S.E.M. of three
ect of 5 mM OMA treatment for 24 h on H-ferritin mRNA level in presence or
scribed in A. The intensity of the bands corresponding to H-ferritin mRNAwas
bar graph as the mean of relative O.D. units±S.E.M. of three independent
Fig. 4. (A) Dose-dependence of the effect of OMA on CATactivity driven by the H-ferritin promoter/CATconstruct 5′-H H/A transiently transfected in 3T3-L1 murine
fibroblasts, as described under Materials and methods. (B) Effect of 5 mMOMA on CATactivity driven by the H-ferritin promoter/CATconstruct 5′-H H/A transiently
transfected in 3T3-L1 cells. (C) Effect of 5 mM OMA on CAT activity driven by the H-ferritin promoter/CAT construct Bbf/TATAA transiently transfected in 3T3-L1
cells. Results are plotted in bar graph and are expressed as percentage of relative CAT activity±S.E.M. of three independent experiments.
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induction could be due to an enhanced transcriptional rate rather
than to an increased stability of pre-existing ferritin mRNA.
3.4. OMA enhances transcriptional efficiency of H-ferritin
promoter
To further investigate the OMA effect on the transcriptional
mechanism of H-ferritin gene, considering that mouse and
human proximal 5′-flanking sequences show a high degree of
homology (78%) in the regulatory region B site [32], we
performed transient transfection assays in presence of plasmidsFig. 5. Electrophoretic mobility-shift assay showing the effect of OMA on the form
extracts from 3T3-L1 cells cultured in presence of OMA for the indicated times and a 3
ferritin gene promoter. Human (see Ref. [31]) and mouse (GenBank accession numbe
the different regions underlined. Specific competition (comp a) was performed with a
accomplished by a 100-fold molar excess of unrelated competitor oligonucleotide. Th
quantified by densitometric and/or phosphorimager analysis and results are plotted
experiments.carrying regions of the human H-ferritin promoter upstream of
CAT reporter gene.
To this aim, we used the 5′-H H/A construct that contains
100 bp upstream the start site of the H-ferritin transcription [30],
the plasmid Bbf/TATAA carrying a 24-bp oligonucleotide
corresponding to the H-ferritin regulatory region (B-site) fused
to the TATAA box [31], and the Bbfmut/TATAA construct
containing a mutated version of the B-site.
The CAT gene expression driven by the various constructs
was assessed by measuring the CAT protein levels by ELISA
and the results were normalized by using CMV-Luc as internal
control. To evaluate the dose-dependence of the effect of OMA,ation of DNA–protein complexes. EMSA was performed with 5 μg of nuclear
2P-labeled double-stranded oligonucleotide corresponding to the B-site of the H-
r M73680) H-ferritin promoter regions corresponding to B-site were aligned and
100-fold molar excess of unlabeled probe; nonspecific competition (comp b) was
e arrow indicates the specific retarded complexes. The intensity of the bands was
in bar graph as the mean of relative O.D. units±S.E.M. of three independent
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construct in 3T3-L1 cells treated with various concentrations
of OMA (1, 2.5, 5 and 10 mM) for 24 h. The results demon-
strated a significant increase in the transcription efficiency of the
H-ferritin gene promoter at 5 mM of OMA, therefore we used
this concentration in all the experiments described herein (Fig.
4A). Subsequently, transfection experiments were performed in
cells treated with 5 mM OMA for 6, 24 and 48 h. The results
obtained using the 5′-H H/A construct demonstrated that OMA-
treatment increased the transcription efficiency of the H-ferritin
promoter, with a maximal response (about 2.3-fold) at 24 h (Fig.
4B). Similar results were obtained using the plasmid Bbf/
TATAA (Fig. 4C). Conversely, the Bbfmut/TATAA construct
showed a basal activity comparable to that given by the TATAA
box only and did not respond to OMA activation (data not
shown). These data indicate that OMA enhances the transcrip-
tion of H-ferritin gene and the promoter region between −62 and
+1 contains the sequence element involved in OMA induction of
the transcription.
3.5. OMA stimulates DNA–protein interaction
It is known that the H-ferritin promoter region from −62 to
−45 nt contains theB-site positive element of regulation [30]which
binds a 120-kDa transcription factor called Bbf that forms in vivo a
complex with the co-activator molecules p300 and CBP [34].
To explore the possibility that OMA might influence the
interactions between this cis-element in the ferritin promoter and
transcriptional factors required for the active transcriptional
complex, we analyzed by EMSA the effect of OMA at 6, 24 and
48 h in nuclear extracts challenged with a 24 bp oligonucleotide
spanning the regulatory region. The results shown in Fig. 5
demonstrated that OMA stimulated the binding capacity of
nuclear proteins in the DNA–protein complex formation,
reaching the maximum at 24 h (about 3.1-fold). These data
suggest that OMA may increase the ability of transcriptional
factors to bind the B-positive site element and/or stabilize this
complex.
4. Discussion
In this report, we present data on the effects of oxalomalate,
an inhibitor of the aconitase enzyme, on ferritin expression and
we show that this compound acts both at post-transcriptional
level on ferritin mRNAs by interacting with IRP1/aconitase and
at transcriptional level by enhancing the H-ferritin promoter
efficiency. We have previously reported that oxalomalate
decreases the RNA binding activity of IRPs to the same
extent in iron-repleted cells, which are rich in aconitase, and in
iron-depleted cells, rich in IRPs [5]. Recently, we have
demonstrated that OMA treatment determines in several cell
lines an increase in intracellular ferritin content that counteracts
the oxidative stress iron-induced [28]. In the present study, we
found that in 3T3-L1 murine fibroblasts exposed to OMA the
amount of IRP1 protein resulted unchanged at all exposure
times examined, whereas IRP1 binding activity was early
inhibited (at 6 h), then slightly increased until 48 h remainingat lower level than untreated cells. These findings suggest that
OMA impairs IRP1 RNA binding ability through specific
interaction with the active site cleft of the protein, without
affecting the IRP1 protein expression. Furthermore, ferritin
biosynthesis exhibited a biphasic response to OMA treatment.
In fact, a rapid increase of ferritin synthesis occurred after 6 h
of treatment in accordance to IRP1 inactivation OMA-induced,
after that ferritin biosynthesis returned to basal levels at 24 h of
treatment in concomitance with IRP1 reactivation. The
prolonged OMA treatment induced a marked increase of H-
ferritin biosynthesis that did not exclusively correlate with IRP1
binding activity. In fact, we observed an increase of H-ferritin
mRNA level at 24 h of OMA exposure that could contribute to
the delayed raise in ferritin biosynthesis. This increase of
mRNA level may be due to an enhanced transcription rather
than a reduction in ferritin mRNA degradation, as supported by
experiments with actinomycin D. Thus, it appears that OMA
affects ferritin expression through the rapid post-transcriptional
mechanism operated by IRPs coupled to a transcriptional
control. To further investigate the OMA effect on transcrip-
tional efficiency of H-ferritin gene, we analyzed the transcrip-
tion of CAT reporter gene driven by human H-ferritin promoter.
The human H-ferritin promoter, as previously reported [30], is
a compact element of about 170 nucleotides upstream the
transcription start site, where are located two cis-elements. The
distal element (termed A box), located at −132 bp from the
transcription start, is recognized by the ubiquitous transcrip-
tional factor Sp1. The proximal element (termed B box),
located from −62 to −45 nucleotides upstream the transcription
start site, is a cAMP-responsive element [31]. The B-site
includes a CCAAT box in inverse orientation and is recognized
by a protein complex containing the transcription factor NFY,
the co-activator p300 and the hystone acetylase P/CAF [34,35].
Comparison of mouse and human sequences in proximal 5′-
flanking region of H-ferritin gene reveals a 78% of sequence
homology in the B-site and a complete conservation of the
inverse CCAAT box [30,32]. Furthermore, it has been
suggested that similar transcriptional mechanisms of H-ferritin
gene are operative in both mouse and human, despite
differences in functional roles and binding complexes between
mouse FER-1 element and human B-site [36].
Consequently, we evaluated the transcriptional efficiency of
the 5′-H H/A construct, containing the −100/+1 region of the
human H-ferritin gene promoter [30] and the Bbf-TATAA
plasmid, containing the B-site fused to the H-ferritin TATAA
box [31] in 3T3-L1 cells cultured in presence or absence of OMA.
The transfection experiments showed that OMA determined an
increase of about 2.3-fold ofH-ferritin promoter activitywith both
constructs. These findings delimit at −62/+1 the target region of
the OMA effect. Moreover, since in human H-ferritin promoter
the −62/+1 region contains the B element (−62 to −45 nt)
identified as a positive regulatory element [31], we analyzed the
OMA effect on this specific region. DNA mobility shift assay of
the B oligonucleotide in presence of nuclear extract of 3T3-L1
cells at different OMA exposure times revealed that OMA
strongly stimulated the formation of a DNA–protein complex,
with a maximum effect at 24 h. Since the high degree of sequence
821R. Santamaria et al. / Biochimica et Biophysica Acta 1763 (2006) 815–822homology of the B-site element in mouse and human H-ferritin
promoter and analogous regulatory nuclear factors, such as p300
and/or P/CAF, are operative for activation of H-ferritin gene
transcription, it is feasible that the high negative charged OMA
molecule might interact with basic amino acid residues present in
the nuclear factors, stabilizing the DNA/protein complex for-
mation. Moreover, it is not to be excluded that OMA can interfere
with molecular mechanisms involved in the activation of tran-
sacting factors, such as phosphorylation/dephosphorylation, and/
or in chromatin remodelling. Of course, to clarify these issues,
further investigations are needed.
In conclusion, the transcriptional activation by OMA of the
ferritin gene seems to be preferential for H-chain subunits. This
observation is in agreement with our previous report showing that
H- and L-chain ferritin levels were higher after 48 h of OMA
exposure in 3T3-NIH fibroblasts, and the increase of H-chain
ferritinwas particularly relevant correlatingwith an increase in the
corresponding mRNA [28]. The subunits composition of ferritin
affects the metabolic properties of the native molecule. In fact, H-
chain rich ferritin accumulates and releases iron faster than L-
chain rich ferritin. It has been demonstrated that H-ferritin plays a
role as an iron cytoprotective agent by limiting the iron-induced
oxidative stress inmature adipocytes [29], in endothelial cells [37]
and in cortical neurons exposed to hypoxia/reoxygenation [19].
Furthermore, in C6 rat glioma cells exposed to iron challenge, a
prolonged treatment with OMA caused a remarkable decrease of
ROS accumulation and a protection of cells from lipid
peroxidation [28].
In the light of these observations, we conclude that OMA
interferes both with transcriptional and translational regulatory
mechanisms involved in ferritin biosynthesis leading to an over-
expression of this protein, in particular the H-subunit that, with
its ability to segregate intracellular iron, limits the availability of
iron to produce oxidant injury of the cells contributing to
oxidative stress cell defence.
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